Patent · US Active

Method of classifying a breast cancer instrinsic subtype

US9631239B2 · kind B2 · utility

4Cited by
18References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 1, 2009
Grant dateApr 25, 2017
Priority date
Expiry dateOct 23, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16B40/00
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

Methods for classifying and for evaluating the prognosis of a subject having breast cancer are provided. The methods include prediction of breast cancer subtype using a supervised algorithm trained to stratify subjects on the basis of breast cancer intrinsic subtype. The prediction model is based on the gene expression profile of the intrinsic genes listed in Table 1. This prediction model can be used to accurately predict the intrinsic subtype of a subject diagnosed with or suspected of having breast cancer. Further provided are compositions and methods for predicting outcome or response to therapy of a subject diagnosed with or suspected of having breast cancer. These methods are useful for guiding or determining treatment options for a subject afflicted with breast cancer. Methods of the invention further include means for evaluating gene expression profiles, including microarrays and quantitative polymerase chain reaction assays, as well as kits comprising reagents for practicing the methods of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.